Sophia Randolph
Chief Medical Officer at ALX Oncology Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ALX Oncology Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ALX Oncology Holdings Inc. June 12, 202467.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −1,365 | $2.58 | $3,522 |
| Jul 1, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −3,273 | $5.82 | $19,049 |
| May 13, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −10,203 | $15.82 | $161,411 |
| May 13, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −1,797 | $16.67 | $29,956 |
| Feb 14, 2024 | ALX Oncology Holdings Inc. | Grant or award | +30,000 | — | — |
| Dec 29, 2023 | ALX Oncology Holdings Inc. | Open-market sale | −3,128 | $15.04 | $47,045 |
| Jul 25, 2023 | ALX Oncology Holdings Inc. | Grant or award | +34,000 | — | — |
| Jun 30, 2023 | ALX Oncology Holdings Inc. | Open-market sale | −1,605 | $7.34 | $11,781 |
| Jun 9, 2023 | ALX Oncology Holdings Inc. | Option exercise | +4,027 | $1.91 | $7,692 |
| Jun 9, 2023 | ALX Oncology Holdings Inc. | Option exercise | +2,546 | $4.08 | $10,388 |
| Jun 9, 2023 | ALX Oncology Holdings Inc. | Option exercise | +6,256 | $4.81 | $30,091 |
| Dec 29, 2022 | ALX Oncology Holdings Inc. | Open-market sale | −1,617 | $11.07 | $17,900 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.